Anders Hedberg, Ph.D. is a former corporate executive with thirty years experience in pharmaceutical R&D and corporate affairs He also is a global leader in advocacy for science, health and education policy reform.
Dr. Hedberg is now bringing his expertise in the practice of science, corporate social responsibility (CSR), and strategic philanthropy to a private consultancy to strengthen the global talent marketplace and STEM education worldwide.
In his recent position as Director, Bristol-Myers Squibb (BMS) Corporate Philanthropy, Dr. Hedberg led the company's worldwide science education program. For ten years his office administrated grant support and strategic program development for numerous educational institutions, ranging from pre-K to higher education, as well as programs for global health education and unrestricted biomedical research grant support.
Under Dr. Hedberg's leadership, the BMS Corporate Social Responsibility Council was established to implement and coordinate global philanthropy with an emphasis on education and alleviation of health disparities.
In addition to being a leader in corporate philanthropy, Dr. Hedberg has served on several national boards, including the National Science Resources Center's National Advisory Board (Chair emeritus), the NSRC International Coalition (Chair), the R&D Council of New Jersey, the Museum of Contemporary Science (Chair emeritus), the Rider University Science Advisory Board (Chair emeritus), the National Alliance of Business, the Conference Board's Education Council, and Teach for America. Dr. Hedberg has served on review boards for National Science Foundation education grant applications and he currently serves on the NSRC US Department of Education i3 Validation Grant advisory board. He is frequently invited to speak at national and international conferences and has made numerous keynote addresses.
Prior to his appointment in Corporate Affairs, Dr. Hedberg created and headed up the BMS Center for Science Education, with responsibility for science communication, education, and training of Bristol-Myers Squibb Research & Development (BMS R&D) scientists worldwide. While serving in that role he also developed a comprehensive science outreach program for BMS that focused on improvement and support of elementary and middle school science education where BMS operates in the U.S., Puerto Rico, Mexico, and Sweden. Dr. Hedberg to established strong alliances between BMS and leading national and international science education agencies in government, private, and nonprofit sectors.
Dr. Hedberg earned his Ph.D. degree in Pharmacology at the School of Medicine, University of Göteborg, Sweden, under supervision and examination of Dr. Arvid Carlsson, the Nobel Laureate in Medicine in 2000. He has taught and conducted research at the Departments of Physiology and Pharmacology, School of Medicine, University of Göteborg; AstraZeneca, Göteborg, Sweden; Universitätsklinikum; Johann Wolfgang Goethe, Frankfurt a/M, Germany; University of Colorado Medical School in Denver; and University of Pennsylvania School of Medicine, where he completed a three-year post-doctoral Fellowship.
For fifteen years, Dr. Hedberg pursued research and published extensively on mechanisms of pharmacological intervention in hypertension, heart failure, myocardial ischemia, and thrombosis. His distinguished career as a leader in drug discovery research has included positions as Principal Scientist, Research Group Leader and Section Head in cardiovascular pharmacology and drug discovery at AstraZeneca and as Sr. Research Investigator and Section Head, Molecular Pharmacology at Bristol-Myers Squibb. He has published extensively in peer-reviewed scientific journals and has presented his research at numerous international conferences.
